相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation
Wenmin Deng et al.
FREE RADICAL BIOLOGY AND MEDICINE (2020)
Synthesis and biological evaluation of parthenolide derivatives with reduced toxicity as potential inhibitors of the NLRP3 inflammasome
Yitao Ou et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Inhibition of Interleukin-1β and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS Trial
Brendan M. Everett et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Glibenclamide attenuates 2,5-hexanedione-induced neurotoxicity in the spinal cord of rats through mitigation of NLRP3 inflammasome activation, neuroinflammation and oxidative stress
Liyan Hou et al.
TOXICOLOGY LETTERS (2020)
Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
Yang Yang et al.
CELL DEATH & DISEASE (2019)
Gout
Nicola Dalbeth et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
A short synthesis of Dronedarone
Barbara Piotrkowska et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Targeting the NLRP3 inflammasome in inflammatory diseases
Matthew S. J. Mangan et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Orchestration of NLRP3 Inflammasome Activation by Ion Fluxes
Tao Gong et al.
TRENDS IN IMMUNOLOGY (2018)
Inflammasome signalling in brain function and neurodegenerative disease
Michael T. Heneka et al.
NATURE REVIEWS NEUROSCIENCE (2018)
Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer's disease
Carmen Venegas et al.
NATURE (2017)
Novel anti-cancer agents based on germacrone: design, synthesis, biological activity, docking studies and MD simulations
Lianbao Ye et al.
RSC ADVANCES (2017)
Molecular mechanisms regulating NLRP3 inflammasome activation
Eun-Kyeong Jo et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Convergent Synthesis of Dronedarone, an Antiarrhythmic Agent
Takashi Okitsu et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2016)
Mechanism and Regulation of NLRP3 Inflammasome Activation
Yuan He et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease
Yun-Hee Youm et al.
NATURE MEDICINE (2015)
Inflammasomes: mechanism of action, role in disease, and therapeutics
Haitao Guo et al.
NATURE MEDICINE (2015)
An Improved and Efficient Process for the Production of Dronedarone Hydrochloride, an Antiarrhythmia Drug
Anil C. Mali et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2013)
Development of novel M1 antagonist scaffolds through the continued optimization of the MLPCN probe ML012
Bruce J. Melancon et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Nimodipine inhibits IL-1β release stimulated by amyloid β from microglia
J. M. Sanz et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Cell Volume Regulation Modulates NLRP3 Inflammasome Activation
Vincent Compan et al.
IMMUNITY (2012)
Regulation of inflammasome signaling
Vijay A. K. Rathinam et al.
NATURE IMMUNOLOGY (2012)
Novel Approaches for Pharmacological Management of Atrial Fibrillation
Joachim R. Ehrlich et al.
DRUGS (2009)
Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
Mohamed Lamkanfi et al.
JOURNAL OF CELL BIOLOGY (2009)
A Selective Matrix Metalloprotease 12 Inhibitor for Potential Treatment of Chronic Obstructive Pulmonary Disease (COPD): Discovery of (S)-2-(8-(Methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408)
Wei Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)